Exendin-4 inhibits structural remodeling and improves Ca 2+ homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS/cGMP/PKG pathway-Reference-Cited by-同舟云学术

Exendin-4 inhibits structural remodeling and improves Ca 2+ homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS/cGMP/PKG pathway

Published:2017-04 Issue: Volume:90 Page:69-77
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Chen Jingjing,Wang Dandan,Wang Fangai,Shi Shaobo,Chen Yuting,Yang Bo,Tang Yanhong,Huang Congxin

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference49 articles.

1. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4;Arakawa;Diabetes,2010

2. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload;Backs;Proc Natl Acad Sci USA,2009

3. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

4. Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: Evidence for improving cardiac metabolic efficiency;Bao;PLoS One,2011

5. Cardiomyocyte-specific overexpression of nitric oxide synthase 3: Impact on left ventricular function and myocardial infarction;Bloch;Trends Cardiovasc Med,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction;Heart Failure Reviews;2024-09-13

2. Unraveling the Cardiac Matrix: From Diabetes to Heart Failure, Exploring Pathways and Potential Medications;Biomedicines;2024-06-13

3. New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions;International Journal of Molecular Sciences;2024-06-05

4. Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects;Pharmaceutics;2024-05-22

5. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists;International Journal of Molecular Sciences;2024-04-30